These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1234505)

  • 1. Effect of age, height, weight and sex on serum phenytoin concentration in epileptic patients.
    Houghton GW; Richens A; Leighton M
    Br J Clin Pharmacol; 1975 Jun; 2(3):251-6. PubMed ID: 1234505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady-state serum levels of anticonvulsant drugs in Chinese epileptic patients living in Taiwan.
    Lai ML
    Ther Drug Monit; 1985; 7(1):83-6. PubMed ID: 3992625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual variation in daily dosage requirements for phenytoin sodium in patients with epilepsy.
    Barot MH; Grant RH; Maheendran KK; Mawer GE; Woodcock BG
    Br J Clin Pharmacol; 1978 Sep; 6(3):267-71. PubMed ID: 687505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum phenytoin determination, its value in the treatment of epilepsy].
    Beier R; Zschiesche M
    Psychiatr Neurol Med Psychol (Leipz); 1977 Feb; 29(2):103-12. PubMed ID: 866497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of increased bioavailability of phenytoin tablets on serum phenytoin concentration in epileptic out-patients.
    Neuvonen PJ; Bardy A; Lehtovaara R
    Br J Clin Pharmacol; 1979 Jul; 8(1):37-41. PubMed ID: 552295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary hydroxyphenytoin/creatinine ratios as an index of compliance in adult epileptic patients on phenytoin therapy.
    Rambeck B; May T
    Ther Drug Monit; 1984; 6(2):164-72. PubMed ID: 6740735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum-phenytoin levels in management of epilepsy.
    Richens A; Dunlop A
    Lancet; 1975 Aug; 2(7928):247-8. PubMed ID: 49797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: Serum-phenytoin and body-weight.
    Ayers GJ; Goudie JH; Burnett D
    Lancet; 1976 Apr; 1(7963):809-10. PubMed ID: 56625
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the effectiveness of two oral phenytoin products and chronopharmacokinetics of phenytoin.
    Petker MA; Morton DJ
    J Clin Pharm Ther; 1993 Jun; 18(3):213-7. PubMed ID: 8345007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between the measured and calculated free serum phenytoin concentrations in epileptic patients.
    Hong JM; Choi YC; Kim WJ
    Yonsei Med J; 2009 Aug; 50(4):517-20. PubMed ID: 19718399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenytoin dosage requirements and pharmacokinetic variables.
    Taylor JW; Murphy MJ; Berg MJ; Perry PJ; Lyon LW; Ludden TM
    Clin Pharm; 1983; 2(3):253-7. PubMed ID: 6883953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum diphenylhydantoin in epileptic patients (preliminary report)].
    Radzikowska B; Zadrozyńska E; Pakszys W
    Neurol Neurochir Pol; 1977; 11(5):551-4. PubMed ID: 593505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti epileptic therapy with diphenylhydantoin with serum controls in childhood. Clinical experiences].
    Nolte R; Brügmann G; Besch W
    Bibl Psychiatr; 1975; (151):43-8. PubMed ID: 1156347
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of spectrophotometric and gas-liquid chromatographic measurements of serum diphenylhydantoin concentrations in epileptic out-patients.
    Janz D; Schmidt D
    J Neurol; 1974 Jun; 207(2):109-16. PubMed ID: 4135844
    [No Abstract]   [Full Text] [Related]  

  • 15. Diphenylhydantoin dosage.
    Eadie MJ; Tyrer JH; Hooper WD
    Proc Aust Assoc Neurol; 1973; 10(0):53-9. PubMed ID: 4792162
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of serum phenytoin levels in epileptic patients who swallowed their phenytoin tablets with or without previous chewing.
    Bielmann P; Levac T
    Eur J Clin Pharmacol; 1978 Nov; 14(3):191-4. PubMed ID: 729613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phenytoin serum concentration in epileptic patients: influence of therapeutic and physiological factors (author's transl)].
    May T; Stenzel E; Rambeck B
    Nervenarzt; 1982 May; 53(5):291-6. PubMed ID: 7099314
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of combination therapy on the plasma concentrations of traditional antiepileptics: a retrospective study.
    Sirmagul B; Atli O; Ilgin S
    Hum Exp Toxicol; 2012 Oct; 31(10):971-80. PubMed ID: 22588177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualization of phenytoin dosage regimens.
    Ludden TM; Allen JP; Valutsky WA; Vicuna AV; Nappi JM; Hoffman SF; Wallace JE; Lalka D; McNay JL
    Clin Pharmacol Ther; 1977 Mar; 21(3):287-93. PubMed ID: 837647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of intravenous phenytoin in children.
    Koren G; Brand N; Halkin H; Dany S; Shahar E; Barzilay Z
    Pediatr Pharmacol (New York); 1984; 4(1):31-8. PubMed ID: 6739185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.